Clinical trials arena news
WebJan 10, 2024 · An expected FDA decision on Amylyx Pharmaceuticals’ Amyotrophic lateral sclerosis (ALS) asset in June will headline a busy year in drug development for this rare disease. Five major trials have results anticipated in 2024, including highly anticipated data from the HEALEY platform study. Free Whitepaper WebApr 13, 2024 · For many years, decentralised trials have been touted as a potential solution to a wide range of clinical trial inefficiencies, from traditional challenges with recruiting and retaining patients to recent, large-scale disruption to …
Clinical trials arena news
Did you know?
WebApr 14, 2024 · Canada-based ATMA Journey Centers has submitted a new trial application to Health Canada to investigate 3,4-Methylenedioxymethamphetamine (MDMA) in … WebMar 3, 2024 · On 1 March, Merck announced the voluntary withdrawal of its Keytruda (pembrolizumab) immunotherapy for the treatment of patients with metastatic small cell …
WebMar 23, 2024 · Risks of adopting advanced technology Cybersecurity risks None William Newton @WillNewton19 William Newton is a Senior Reporter for Clinical Trials Arena and Pharmaceutical Technology, focusing on clinical trial design, healthcare business and regulation, and new technologies. WebApr 4, 2024 · The simulation model powered by Eisai’s Phase III Clarity AD trial data shows that lecanemab has improved long-term health outcomes compared to the standard of care (SoC) alone. The simulation suggests that patients with mild cognitive impairment due to Alzheimer’s disease (AD) have a slower rate of disease progression and remain in early ...
WebHome - Clinical Trials Arena Features Breaking the mold: How digital endpoints could transform clinical trials Digital endpoints could revolutionize how clinical trials measure … Clinical Trials Arena + Weekly. Newsletter: Decoded . Curated analysis and data … About Us. Clinicaltrialsarena.com is one of a network of 30+ proprietary B2B … Get industry leading news, data and analysis delivered to your inbox. … Awards & Rankings. The Clinical Trials Arena Excellence Awards celebrate the … Breaking the mold: How digital endpoints could transform clinical trials Exposure … Clinical Trials Arena Reports GlobalData’s reports offer expert analysis, insights … Testimonials “We at Bürkert chose to work with Pharma Technology Focus online … Clinical Trials; Approvals; Operations; Outsourced Services; Supply Chain; … Industry News Archives - Clinical Trials Arena Industry News News Children’s … TILT Biotherapeutics and MSD (Merck) have entered a clinical trial … WebApr 13, 2024 · For many years, decentralised trials have been touted as a potential solution to a wide range of clinical trial inefficiencies, from traditional challenges with recruiting …
WebSep 16, 2024 · The news of the trial comes just weeks after it was announced that J&J’s recent efforts at an HIV vaccine had failed and news broke that Moderna is set to begin …
WebClinical Trials; Approvals; Operations; Outsourced Services; Supply Chain; Data Management; Medical Devices; Latest. Enlivex gains authorisation for Allocetra trial … leek stoves and fireplacesWebApr 10, 2024 · @WillNewton19 William Newton is a Senior Reporter for Clinical Trials Arena and Pharmaceutical Technology, focusing on clinical trial design, healthcare … leek staffordshire train stationWebDecentralised clinical trials companies in clinical research Leading artificial intelligence (AI) companies in clinical trials Leading Cloud computing companies in clinical trials … leek to ashbourne road conditionsWebApr 13, 2024 · Allegro Ophthalmics has its sights set on a Phase II/III trial in dry age-related macular degeneration (AMD) after receiving a regulatory stamp of approval. Allegro … leek taxi servicesWebApr 1, 2024 · German biopharmaceutical firm InflaRx has enrolled and dosed the first patient in a clinical study of IFX-1 in Covid-19 patients with severe pneumonia in the Netherlands. IFX-1 is a monoclonal anti-human complement factor C5a antibody designed to inhibit the biological activity of C5a. The drug is not believed to impact the formation of the ... leek to hanley bus timesWebJan 13, 2024 · In Phase III trials of Aduhelm and lecanemab, ARIA-E occurred in 35% and 12.5% of patients, respectively. While ARIA-E is common among antibodies targeting AD, some researchers believe AD vaccines could act on similar targets without this safety concern. 1. What are your thoughts on generative AI? It is all hype and no substance leek to hanley bus timetableWebApr 12, 2024 · Urtė Fultinavičiūtė. US-based Quoin Pharmaceuticals is recruiting a paediatric population into its ongoing Phase II/III trial investigating QRX003 in Netherton syndrome (NS), CEO Dr Michael Myers told Clinical Trials Arena. QRX003 is a broad-spectrum serine protease inhibitor that down-regulates the hyperactivity of skin kallikreins. leeks with cheese sauce